Replacing a biotech legend, Gilead’s new CEO inherits sky-high expectations

Damian Garde

John Martin, the man who led Gilead Sciences from the basements of to the verge of Big Pharma, is stepping down after 20 years, with longtime lieutenant John Milligan in line to take his place.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS